Psychological aspects of press reports vs. actual possibilities of genetic testing in oncology;Informacje prasowe a rzeczywiste mozliwości poradnictwa genetycznego w aspekcie psychoonkologicznym

Wspolczesna Onkologia

Volumn 10, Issue 7, 2006, Pages 313-315

  Litwiniuk, Maria ^a   Karolczak, Grazyna ^a   Breborowicz, Elzbieta ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Familial breast cancer; Genetic testing; Psychological impact

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER THERAPY; DECISION MAKING; DISTRESS SYNDROME; EARLY DIAGNOSIS; FEMALE; GENETIC SCREENING; HUMAN; MAMMOGRAPHY; MASS MEDIUM; MEDICAL INFORMATION; PATIENT COUNSELING; POLAND; PSYCHOLOGICAL ASPECT;

EID: 33748483290     PISSN: 14282526     EISSN: 14282526     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wojciechowska U, Didkowska J, Tarkowski W, Zatoński W. Nowotwory złośliwe w Polsce w 2002 roku. Cancer in Poland in 2002. Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warszawa 2004.
2. Martin AM, Weber BL. Genetic and hormonal risk factor in breast cancer. J Natl Cancer Inst 2000; 92: 1126-35.
3. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.
4. Gorski B, Jakubowska A, Huzarski T, et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004; 110: 683-6.
5. Narod SA, Offit K. Prevention and management of hereditary breast cancer. J Clin Oncol 2005; 23: 1656-63.
6. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001; 19: 3524-31.
7. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002; 346: 1616-22.
8. Thirlaway K, Fallowfield L, Nunnerley H, Powles T. Anxiety in women "at risk" of developing breast cancer. Br J Cancer 1996; 73: 1422-4.
9. Cella D, Hughes C, Peterman A, et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002; 21: 564-72.
10. Reichelt JG, Heimdal K, Moller P, Dahl AA. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 2004; 3: 21-8.
11. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996; 275: 1885-92.
12. Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002; 20: 514-520.
13. van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003; 21: 3867-74.
14. Halbert CH. Decisions and outcomes of genetic testing for inherited breast cancer risk. An Oncol 2004; 15 (supl. 1): i35-i39.
15. Mosconi P, Leccese A. Genetic testing and breast cancer: the women's point of view. An Oncol 2004; 15 (supl. 1): i40-i42.
16. Phelps C, Platt K, France L, Gray J, Iredale R. Delivering information about cancer genetics via letter to patients at low and moderate risk of familial cancer: a pilot study in Wales. Fam Cancer 2004; 3: 55-9.